Home › Funds › UBS Group AG › ABVX
UBS Group AG position in ABVX
ABIVAX SA · Health Care
Latest position (Q2 2026)1.86M sh
Reported value held$247.95M
Portfolio Weight0.03%
First reportedQ1 2024
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 3 | $43 | New |
| Q3 2024 | 691 | $7.96K | New |
| Q4 2024 | 174.87K | $1.28M | Add |
| Q1 2025 | 162.55K | $1.02M | Reduce |
| Q2 2025 | 167.66K | $1.28M | Add |
| Q3 2025 | 4.46M | $378.76M | Add |
| Q4 2025 | 4.42M | $596.59M | Reduce |
| Q1 2026 | 4.55M | $506.35M | Add |
| Q2 2026 | 1.86M | $247.95M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ABVX
- Citadel Advisors 4.24M sh · $565.52M · Q2 2026
- Morgan Stanley 1.43M sh · $190.85M · Q2 2026
- Norges Bank Investment Management 1.10M sh · $146.59M · Q2 2026
- Bank of America Corp 971.44K sh · $129.45M · Q2 2026
- Goldman Sachs Group 792.71K sh · $105.64M · Q2 2026
- Janus Henderson Group 878.83K sh · $98.01M · Q1 2026
- Balyasny Asset Management 624.44K sh · $83.21M · Q2 2026
- BlackRock Inc 574.06K sh · $76.50M · Q2 2026
- Millennium Management 307.64K sh · $41.00M · Q2 2026
- Franklin Resources 299.75K sh · $39.95M · Q2 2026
- Principal Global Investors 257.68K sh · $34.34M · Q2 2026